Gain Therapeutics Inc. (GANX)
NASDAQ: GANXHealth CareBiotechnology: Pharmaceutical PreparationsUSD
Market open · Delayed 15 min · as of Oct 8, 11:07 AM ET
GANX stock chart
Technical analysisKey statistics
All statistics- Market cap
- $70.70M
- EPS (TTM)
- -$0.50
- Dividend yield
- None
- 52-week range
- 1.53 – 4.34
- Day range
- 1.61 – 1.68
- Volume / Avg
- 124.99K / 497.54K
- Beta
- —
- Shares outstanding
- 43.64M
52-week range
GANX stock today
On Oct 8, GANX is trading at $1.62, shedding $0.05 (2.99%), versus the S&P 500's 0.28% decline. At this level, GANX sits near the bottom of its 52-week range of $1.53 to $4.34: 62.7% below the high, set on Dec 11, 2025 and 5.9% above the low. GANX is down 48.1% year to date, underperforming the S&P 500 (+14.0%). Over the past 12 months, the stock has lost 17.3%.
Gain Therapeutics has posted a net loss over the last twelve months (EPS of -$0.50), so its P/E ratio is not meaningful.
Summary generated from market data by MetaCap's automated system. Methodology
About Gain Therapeutics
Company profile- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- IPO year
- 2021
Gain Therapeutics peers
Health Care sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| ONCYOncolytics Biotech Inc. | 0.5575 | -6.43% | $73.10M | vs GANX |
| NTHINeOnc Technologies Holdings Inc. | 2.56 | -5.54% | $73.74M | vs GANX |
| OSTXOS Therapies Incorporated | 1.59 | +2.58% | $74.42M | vs GANX |
| VRCAVerrica Pharmaceuticals Inc. | 4.14 | 0.00% | $71.12M | vs GANX |
| CINGCingulate Inc. | 4.85 | -0.36% | $70.56M | vs GANX |
| MAIAMAIA Biotechnology Inc. | 1.14 | -3.81% | $70.08M | vs GANX |
| PDSBPDS Biotechnology Corporation | 1.05 | -1.41% | $76.10M | vs GANX |
| LFVNLifevantage Corporation | 6.05 | +0.83% | $76.17M | vs GANX |
Indexes, lists and sector
Gain Therapeutics stock FAQ
What is Gain Therapeutics's stock price today?
GANX last traded at $1.62 as of Oct 8, 11:07 AM EDT, down 2.99% on the day. Prices are delayed at least 15 minutes.
What is the GANX 52-week high?
The 52-week high for GANX is $4.34 and the 52-week low is $1.53. The stock is currently 62.7% below its high.